Biomet’s net sales were also up 4.5 percent this past quarter, totaling $825.7 million. Spine sales increased 2.3 percent from $102.6 million to $104.9 million. The biggest growth was seen in knees, which increased 6.6 percent to $264 million.
The company’s 2012 acquisition of DePuy Orthopaedic’s trauma products has helped increase growth over the last year.
More Articles on Devices:
Where the Spine Device Field is Headed: Q&A With Invibio’s Michael Veldman
Stryker, NeuroLogica Enter Exclusive Partnership Agreement to Better Facilitate Image-Guided Surgery
Device Companies — 11 Key Notes — Medtronic, Stryker, Zimmer & More
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
